Eledon Pharmaceuticals Inc has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on May 11, 2017 with the ratio of 1-for-9, meaning that for 9 shares of ELDN owned pre-split, shareholders then owned 1 share. The most recent stock split took place on October 05, 2020 on a 1-for-18 basis.
These actions have increased ELDN stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Eledon Pharmaceuticals Inc's total market capitalization.
For more detailed information of Eledon Pharmaceuticals Inc's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Eledon Pharmaceuticals Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when ELDN stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Eledon Pharmaceuticals Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
